Th2 bias of CD4+ NKT cells derived from multiple sclerosis in remission

International Immunology

Volumn 15, Issue 2, 2003, Pages 279-288

  Araki, Manabu ^a   Kondo, Takayuki ^a   Gumperz, Jenny E ^b   Brenner, Michael B ^b   Miyake, Sachiko ^a   Yamamura, Takashi ^a  

^a NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

galactosylceramide; CD4+ NKT cell; Immunoregulation; Multiple sclerosis; Th2 bias

Indexed keywords

CD1D ANTIGEN; CD4 ANTIGEN; CYTOKINE; GALACTOSYLCERAMIDE; GAMMA INTERFERON; INTERLEUKIN 4;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOREGULATION; IN VIVO STUDY; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; MALE; MONONUCLEAR CELL; MULTIPLE SCLEROSIS; NATURAL KILLER CELL; PHENOTYPE; PRIORITY JOURNAL; RELAPSE; REMISSION; STATISTICAL ANALYSIS; TH1 CELL; TH2 CELL; CD4+ T LYMPHOCYTE; METABOLISM;

ADULT; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; GALACTOSYLCERAMIDES; HUMANS; KILLER CELLS, NATURAL; MALE; MULTIPLE SCLEROSIS; TH2 CELLS;

EID: 0037328355     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/dxg029     Document Type: Article

References (40)

1. Martin, R., Ruddle, N. H., Reingold, S. and Hafler, D. A. 1998. T helper cell differentiation in multiple sclerosis and autoimmunity. Immunol. Today 19:495.
2. Steinman, L. 2001. Multiple sclerosis: a two-stage disease. Nat. Immunol. 2:762.
3. h2 balance in autoimmune disease. Curr. Opin. Immunol. 8:837.
4. h3 cells and oral administration of IL-4 enhances oral tolerance in experimental allergic encephalomyelitis. Eur. J. Immunol. 28:2780.
5. + suppressor T cells. J. Exp. Med, 193:F41.
6. Zhang, B. N., Yamamura, T., Kondo, T., Fujiwara, M. and Tabira, T. 1997. Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells. J. Exp. Med. 186:1677.
7. Takahashi, K., Miyake, S., Kondo, T., Terao, K., Hatakenaka, M., Hashimoto, S. and Yamamura, T. 2001. Natural killer type 2 bias in remission of multiple sclerosis, J. Clin. Invest. 107:R23.
8. Martin, R. and McFarland, H. F. 1995. Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis. Crit. Rev. Clin. Lab. Sci. 32:121.
9. Panich, H. S., Hirsch, R. L., Schindler, J. and Johnson, K. P. 1987. Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system. Neurology 37:1097.
10. Kozovska, M. E., Hong, J., Zang, Y. C., Li, S., Rivera, V. M., Killian, J. M. and Zhang, J. Z. 1999. Interferon-β induces T-helper 2 immune deviation in MS. Neurology 53:1692.
11. Neuhaus, O., Farina, C., Yassouridis, A., Wiendl, H., Then Bergh, F., Dose, T., Wekerle, H. and Hohlfeld, R. 2000. Multiple sclerosis: comparison of copolymer-1 -reactive T cell lines from treated and untreated subjects reveals cytokine shift from T helper 1 to T helper 2 cells. Proc. Natl Acad. Sci. USA 97:7452.
12. h2-polarized immune responses in patients with multiple sclerosis. J. Clin. Invest. 105:967.
13. Bendelac, A., Rivera, M. N., Park, S. and Roark, J. H. 1997. Mouse CD-1-specific NK1 T cells: development, specificity and function. Annu. Rev. Immunol. 15:535.
14. Godfrey, D. I., Hammond, K. J., Poulton, L. D., Smyth, M. J. and Baxter, A. G. 2000. NKT cells: facts, functions and fallacies. Immunol. Today 21:573.
15. +CD4-CD8- NKT thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabeteic (NOD)/Lt mice by the influence of interleulkin (IL)-4 and/or IL-10. J. Exp. Med. 187:1047.
16. α281 transgenic nonobese diabetic mice against diabetes. J. Exp. Med. 188:1831.
17. Wang, B., Geng, Y. B. and Wang C. R. 2001. CD1-restricted NK T cells protect nonobese diabetic mice from developing diabetes. J. Exp. Med. 194:313.
18. Hong, S., Wilson, M. T., Serizawa, I., Wu, L., Singh, N., Naidenko, O. V., Miura, T., Haba, T., Scherer, D. C., Wei, J., Koronenberg, M., Koezuka, Y. and van Kaer, L. 2001. The natural killer T-cell ligand alpha-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. Nat. Med. 7:1052.
19. Sharif, S., Arreaza, G. A., Zucker, P., Mi, Q. S., Sondhi, J., Naidenko, O. V., Kronenberg, M., Koezuka, Y., Delovitch, T. L., Gombert, J. M., Leite-De-Moraes, M., Gouarin, C., Zhu, R., Hameg, A., Nakayama, T., Taniguchi, M., Lepault, F., Lehuen, A., Bach, J. F. and Herbelin, A. 2001. Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes. Nat. Med. 7:1057.
20. α14 NK T cells. J. Immunol. 166:662.
21. H2 bias of natural killer T cells. Nature 413:531.
22. Giaccone, G., Punt, C., Ando, Y., Ruijter, R., Nishi, N., Peters, M., von Blomberg, B. M. E., Scheper, R., Roelvink, M., Beijnen, J., Zwierzina, H. and Pinedo, H. 2000. KRN7000, an NKT cell enhancer, in patients with solid tumors. A phase I study of the EORTC BTDG. Proc. Am. Soc. Clin. Oncol. 19:1871(abstr).
23. αQ invariant TCR chain in the lesions of multiple sclerosis and chronic inflammatory demyelinating polyneuropathy. J. Immunol. 164:4375.
24. Yamazaki, K., Ohsawa, Y. and Yoshie H. 2001. Elevated proportion of natural killer T cells in periodontitis lesions. Am. J. Pathol. 158:1391.
25. Mempel, M., Ronet, C., Suarez, F., Gilleron, M., Puzo, G., van Kaer, L., Lehuen, A., Kourilsky, P. and Gachelin, G. 2002. Natural killer T cells restricted by the monomorphic MHC class Ib CD1d1 molecules behave like inflammatory cells. J. Immunol. 168:365.
26. αQ antigen receptor in patients with systemic sclerosis. J. Exp. Med. 182:1163.
27. αQ T cells in type 1 diabetes. Nature 391:177.
28. + NKT cell numbers are decreased in a wide variety of diseases that are characterized by autoreactive tissue damage. Clin. Immunol. 100:144.
29. + double-negative regulatory natural killer T cells in autoimmune diseases. Arthritis Rheum. 44:1127.
30. αQ T cells in peripheral blood of patients with relapsing-remitting multiple sclerosis. Clin. Immunol. 98:11.
31. Gumperz, J. E., Miyake, S., Yamamura, T. and Brenner, M. B. 2002. Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining. J. Exp. Med. 195:625.
32. Lee, P. T., Benlagha, K., Teyton, L. and Bendelac, A. 2002. Distinct functional lineages of human Vα24 natural killer T cells. J. Exp. Med. 195:637.
33. Morita, M., Natori, T., Akimoto, K., Osawa, T., Fukushima, H. and Koezuka, Y. 1995. Synthesis of α-, β-monoglycosylceramides and four diasteromers of an α-galactosylceramide. Bioorg. Med. Chem. Lett. 5:699.
34. hO subpopulation. J. Immunol. 159:5862.
35. Manz, R., Assenmacher, M., Pfluger, E., Miltenyi, S. and Radbruch, A. 1995. Analysis and sorting of live cells according to secreted molecules relocate to a cell-surface affinity matrix. Proc. Natl Acad. Sci. USA 92:1921.
36. Kadowaki, N., Antonenko, S., Ho, S., Rissoan, M.-C., Sournelis, V., Porcelli, S. A., Lanier, L. L. and Liu, Y.-J. 2001. Distinct cytokine profiles of neonatal natural killer T cells after expansion with subsets of dendritic cells. J. Exp. Med. 193:1221.
37. Davodeau, F., Peyrat, M., Necker, A., Dominici, R., Blanchard, F., Leget, C., Gaschet, J., Costa, P., Jacques, Y., Godard, A, Vié, H., Poggi, A., Romagné, F. and Bonneville, M. 1997. Close phenotypic and functional similarities between human and murine αβ T cells expressing invariant TCR α-chains. J. Immunol. 158:5603.
38. + NKT cells activated by α-glycosylceramide-pulsed monocyte-derived dendritic cells. J. Immunol. 164:4458.
39. + T cells in IL-12-induced immune responses in vivo. J. Immunol. 160:16.
40. Leite-De-Moraes, M. C., Moreau, G., Arnould, A., Machavoine, F., Garcia, C., Papiernik, M. and Dy, M. 1998. IL-4 producing NKT cells are biased towards IFN-gamma production by IL-12. Influence of the microenvironment on the functional capacities of NKT cells. Eur. J. Immunol. 28:1507.